Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
9.27
+0.12 (1.31%)
At close: May 29, 2025, 4:00 PM
9.30
+0.03 (0.32%)
After-hours: May 29, 2025, 4:04 PM EDT
Theravance Biopharma Employees
Theravance Biopharma had 97 employees as of December 31, 2024. The number of employees decreased by 2 or -2.02% compared to the previous year.
Employees
97
Change (1Y)
-2
Growth (1Y)
-2.02%
Revenue / Employee
$672,845
Profits / Employee
-$601,371
Market Cap
465.01M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
TBPH News
- 16 days ago - Theravance Biopharma to Participate in an Upcoming Investor Conference - PRNewsWire
- 19 days ago - Theravance Biopharma, Inc. (TBPH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Theravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress - PRNewsWire
- 21 days ago - Theravance Biopharma, Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 4 weeks ago - Theravance to Present Analyses of Ampreloxetine and Neurogenic Orthostatic Hypotension at the 2025 International MSA Congress - PRNewsWire
- 5 weeks ago - Theravance Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025 - PRNewsWire
- 7 weeks ago - Theravance Biopharma Presents Two New Ampreloxetine Analyses in Oral Session at the American Academy of Neurology 2025 Annual Meeting - PRNewsWire
- 2 months ago - Theravance Biopharma to Present New Ampreloxetine Analyses in Neurogenic Orthostatic Hypotension (nOH) at the 77th Annual Meeting of the American Academy of Neurology - PRNewsWire